Body composition changes during weight reduction with tirzepatide in SURMOUNT-1
Genentech announces positive phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity
The original clinical development, by the Canadian biotech ConjuChem, was discontinued, and there is no validated disease endpoint for either version
It exists solely to let your gastrointestinal system adjust
Laser-focused on these goals as well as losing weight (which can also put type-two diabetes in remission), she visited a well-known endocrinologist in Manhattan and asked about Ozempic after reading about it in the New York Times
In contrast, loss of ACSL4 or overexpression of GPX4 can prevent ferroptosis in T cells [89,90,91,92]